BioAtla
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioAtla generated cash of -$104,015,000, which is less than the previous year. Cash used in financing activities reached the amount of $77,000 last year. Net change in cash is therefore -$104,036,000.
Cash Flow
| 2018 | -35.31M | -988K | 5.01M |
|---|---|---|---|
| 2019 | -9.64M | -1.50M | 3.99M |
| 2020 | -36.33M | -590K | 271.82M |
| 2021 | -62.21M | -924K | 69.51M |
| 2022 | -90.42M | -265K | 61.21K |
| 2023 | -104.01M | -98K | 77K |
BCAB Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 215.50M | 244.97M | 238.60M | 3.70M | 10.86M | 42.14M |
Operating activities | ||||||
Net income | -123.46M | -106.48M | -95.40M | -35.85M | -29.85M | -28.97M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 1.22M | 1.19M | 1.33M | 1.00M | 860K | 794K |
Stock-based compensation expense | 13.54M | 14.56M | 25.11M | 3.02M | -6.40K | 0 |
| Deferred income tax benefit | 13.54M | 14.56M | 25.11M | 3.02M | -6.40K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 5.28M | 3 | 7.99M | -1.66M | 3.13M | 446K |
Cash generated by operating activities | -104.01M | -90.42M | -62.21M | -36.33M | -9.64M | -35.31M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -98K | -268K | -924K | -590K | -1.50M | -988K |
Acquisitions Net | 0 | 3K | 0 | -19K | -5K | 0 |
Cash generated by investing activities | -98K | -265K | -924K | -590K | -1.50M | -988K |
Financing activities | ||||||
Common Stock Issued | 336K | 61.68M | 71.42M | 200.22M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -259 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -3.43M | 4M | 0 |
Cash used in financing activities | 77K | 61.21K | 69.51M | 271.82M | 3.99M | 5.01M |
Net Change In Cash | -104.03M | -29.47M | 6.37M | 234.90M | -7.15M | -31.28M |
Cash at end of period | 111.47M | 215.50M | 244.97M | 238.60M | 3.70M | 10.86M |
| Data source | Data source | Data source | Data source |